Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Mulder

Showing results (61-70 of 116) with videos related to

Pageof 12
Sort By:
Journal of Molecular and Cellular Cardiology|June 7, 2011
Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprololYuehua Fang, Lionel Nicol, Najah Harouki, et al.
Journal of Molecular and Cellular Cardiology|December 14, 2011
Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failureNassiba Merabet, Jeremy Bellien, Etienne Glevarec, et al.
Fundamental & Clinical Pharmacology|June 30, 2010
Reduced cardiac remodelling and prevention of glutathione deficiency after omega-3 supplementation in chronic heart failureYuehua Fang, Julie Favre, Magalie Vercauteren, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Increased level of phosphorylated desmin and its degradation products in heart failureMarion Bouvet, Emilie Dubois-Deruy, Tchilabalo Dilezitoko Alayi, et al.
Fundamental & Clinical Pharmacology|April 9, 2025
Dual ET<sub>A</sub>-ET<sub>B</sub> receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fractionFrancesca Lockwood, Marianne Lachaux, Najah Harouki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 24, 2018
Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in miceMarie Besnier, David Coquerel, Julie Favre, et al.
Cardiovascular Research|April 29, 2015
Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failureEmilie Dubois-Deruy, Aude Belliard, Paul Mulder, et al.
Circulation|November 15, 2006
Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failureMagali Vercauteren, Elise Remy, Corinne Devaux, et al.
Plos One|May 15, 2009
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa)Abdelali Agouni, Anne-Hélène Lagrue-Lak-Hal, Hadj Ahmed Mostefai, et al.
International Journal of Molecular Sciences|November 26, 2022
Protein Alterations in Cardiac Ischemia/Reperfusion Revealed by Spatial-OmicsStephanie T P Mezger, Alma M A Mingels, Matthieu Soulié, et al.
Pageof 12

Showing results (61-70 of 116) with videos related to

Sort By:
Pageof 12
Journal of Molecular and Cellular Cardiology|June 7, 2011
Improvement of left ventricular diastolic function induced by β-blockade: a comparison between nebivolol and metoprololYuehua Fang, Lionel Nicol, Najah Harouki, et al.
Journal of Molecular and Cellular Cardiology|December 14, 2011
Soluble epoxide hydrolase inhibition improves myocardial perfusion and function in experimental heart failureNassiba Merabet, Jeremy Bellien, Etienne Glevarec, et al.
Fundamental & Clinical Pharmacology|June 30, 2010
Reduced cardiac remodelling and prevention of glutathione deficiency after omega-3 supplementation in chronic heart failureYuehua Fang, Julie Favre, Magalie Vercauteren, et al.
Biochemistry and Biophysics Reports|September 29, 2017
Increased level of phosphorylated desmin and its degradation products in heart failureMarion Bouvet, Emilie Dubois-Deruy, Tchilabalo Dilezitoko Alayi, et al.
Fundamental & Clinical Pharmacology|April 9, 2025
Dual ET<sub>A</sub>-ET<sub>B</sub> receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fractionFrancesca Lockwood, Marianne Lachaux, Najah Harouki, et al.
American Journal of Physiology. Heart and Circulatory Physiology|March 24, 2018
Protein tyrosine phosphatase 1B inactivation limits aging-associated heart failure in miceMarie Besnier, David Coquerel, Julie Favre, et al.
Cardiovascular Research|April 29, 2015
Interplay between troponin T phosphorylation and O-N-acetylglucosaminylation in ischaemic heart failureEmilie Dubois-Deruy, Aude Belliard, Paul Mulder, et al.
Circulation|November 15, 2006
Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failureMagali Vercauteren, Elise Remy, Corinne Devaux, et al.
Plos One|May 15, 2009
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa)Abdelali Agouni, Anne-Hélène Lagrue-Lak-Hal, Hadj Ahmed Mostefai, et al.
International Journal of Molecular Sciences|November 26, 2022
Protein Alterations in Cardiac Ischemia/Reperfusion Revealed by Spatial-OmicsStephanie T P Mezger, Alma M A Mingels, Matthieu Soulié, et al.
Pageof 12